Despite Fast-paced Momentum, NewtekOne (NEWT) Is Still a Bargain Stock

NewtekOne (NEWT), a provider of financial and business services, is identified as a compelling investment opportunity, exhibiting both fast-paced momentum and a bargain valuation. The stock has gained 14.1% over the past 12 weeks with a beta of 1.25, earning a favorable Zacks Momentum Score of 'B' and a Zacks Rank #2 (Buy) due to upward earnings estimate revisions. Despite this strong price performance, NEWT remains attractively valued with a Price-to-Sales ratio of 0.86, suggesting significant potential for continued upside.

Analysis

NewtekOne (NEWT), a financial and business services provider, has been identified as a stock exhibiting strong momentum characteristics combined with an attractive valuation. The company's shares have demonstrated significant price momentum, with a gain of 14.1% over the past 12 weeks and 2.7% in the last four weeks. This performance is coupled with a beta of 1.25, indicating that the stock's price movements are historically 25% more volatile than the broader market. The positive trend is supported by fundamental signals, specifically upward revisions in earnings estimates from covering analysts, which have earned the stock a Zacks Rank #2 (Buy) and a Momentum Score of 'B'. Despite this strong performance and bullish sentiment, NEWT maintains a Price-to-Sales (P/S) ratio of 0.86, a metric suggesting the stock is trading at a discount relative to its revenues. This combination of positive technical momentum, favorable analyst revisions, and a low valuation multiple forms the basis of the current investment thesis.

Key Decisions for Investors

• Investors with an appetite for growth at a reasonable price may find NEWT compelling, given its dual characteristics of strong price momentum and a low Price-to-Sales ratio of 0.86.
• The stock's beta of 1.25 implies higher volatility than the market; therefore, any position should be sized to account for potentially larger price swings in both directions.
• The investment case is heavily tied to ongoing positive earnings estimate revisions, so investors should closely monitor analyst sentiment and future earnings reports for any signs of a deteriorating outlook.